1|Page
NR566 ADVANCED PHARMACOLOGY
FOR CARE OF THE FAMILY — WEEK 8
FINAL PRACTICE QUESTIONS 1–100
AND ANSWERS UPDATED 2026/2027 |
DETAILED RATIONALES
INTRODUCTION
NR566 Advanced Pharmacology for Care of the Family requires advanced application of
pharmacologic principles across the lifespan. Publicly available 2026 course study materials
describe the Week 8 final as a multiple-choice assessment covering Weeks 5–8, with major
content areas including pharmacotherapy for the eyes, ears, nose, and skin; mental-health
pharmacotherapy; CNS disorders; and health promotion and weight-loss pharmacotherapy.
This practice bank is designed to help students prepare for challenging clinical decision-making
questions rather than simple medication memorization. The questions emphasize mechanism of
action, adverse effects, contraindications, drug interactions, monitoring, patient-specific
prescribing, lifespan considerations, and appropriate patient education. Scenarios require the
learner to integrate symptoms, comorbidities, laboratory findings, medication histories, and
safety considerations before selecting the best pharmacologic intervention. Topics include
antihistamines, corticosteroids, allergic-rhinitis therapy, psychiatric medications, antidepressants,
antipsychotics, mood stabilizers, CNS medications, Parkinson disease, Alzheimer disease,
migraine therapy, smoking cessation, immunization, obesity pharmacotherapy, and medication
safety. The goal is to provide rigorous self-assessment and identify knowledge gaps that should
be reviewed against assigned course materials and current prescribing guidance.
CONTENT AREA OVERVIEW
Content Area Questions Key Topics Weight
Antihistamines, glucocorticoids, allergic rhinitis,
Week 5 — Eyes, Ears,
1–25 cough/cold therapy, dermatologic and sensory 25%
Nose & Skin
pharmacotherapy
Depression, anxiety, bipolar disorder,
Week 6 — Mental
26–50 antipsychotics, antidepressants, mood stabilizers, 25%
Health
monitoring
Parkinson disease, Alzheimer disease, migraine,
Week 7 — CNS
51–75 seizure/CNS pharmacotherapy, neurologic adverse 25%
Disorders
effects
,2|Page
Content Area Questions Key Topics Weight
Week 8 — Health Smoking cessation, vaccines, obesity
Promotion & Weight 76–100 pharmacotherapy, contraindications, adverse 25%
Loss effects, lifestyle integration
QUESTIONS 1–100
WEEK 5 — PHARMACOTHERAPY FOR EYES, EARS,
NOSE & SKIN
Q1:
A 72-year-old patient with allergic rhinitis, benign prostatic hyperplasia, and narrow-angle
glaucoma asks for an over-the-counter antihistamine. Which prescribing consideration is most
important?
A) A first-generation antihistamine is preferred because it has stronger anticholinergic activity
B) A second-generation antihistamine is generally preferable because first-generation
agents can worsen anticholinergic and CNS effects
C) Diphenhydramine should be used at bedtime indefinitely
D) All antihistamines are contraindicated in older adults
Rationale: First-generation antihistamines have significant anticholinergic and sedating effects
that can worsen urinary retention and potentially aggravate glaucoma-related concerns. A
second-generation agent is generally preferred when an antihistamine is appropriate. Option A
is incorrect because stronger anticholinergic activity is undesirable here. Option C is
inappropriate because chronic use of a sedating first-generation agent creates unnecessary risk.
Option D is too broad; antihistamines are not universally contraindicated in older adults.
Q2:
A patient taking diphenhydramine reports that they feel awake but have difficulty performing a
complex driving task. Which counseling point is most appropriate?
A) Driving impairment occurs only when the patient reports feeling sleepy
B) First-generation antihistamines can impair reaction time and alertness even when
subjective sedation is not obvious
C) The medication improves psychomotor performance
D) Alcohol will eliminate the impairment
Rationale: First-generation antihistamines can impair psychomotor performance and reaction
time even when the patient does not perceive significant drowsiness. Alcohol and other CNS
depressants can worsen impairment. Therefore, patients should be counseled regarding driving
and hazardous activities.
,3|Page
Q3:
A 68-year-old patient with chronic allergic rhinitis has urinary hesitancy and constipation. Which
medication would create the greatest concern?
A) Fexofenadine
B) Loratadine
C) Diphenhydramine
D) Desloratadine
Rationale: Diphenhydramine is a first-generation antihistamine with substantial anticholinergic
activity, which can worsen urinary retention and constipation. The second-generation agents
listed generally have less anticholinergic and sedating activity.
Q4:
A patient with allergic rhinitis has persistent nasal congestion despite intermittent oral
antihistamine use. Which pharmacologic strategy is most appropriate when an intranasal
corticosteroid is not contraindicated?
A) Replace the antihistamine with an oral antibiotic
B) Use an intranasal corticosteroid consistently because it directly reduces nasal
inflammatory activity
C) Use an opioid cough suppressant
D) Begin systemic corticosteroids indefinitely
Rationale: Intranasal corticosteroids are highly effective for allergic rhinitis because they
reduce local inflammatory activity and symptoms such as congestion. Oral antibiotics have no
role in uncomplicated allergic rhinitis. Opioid cough suppressants do not treat nasal
inflammation. Long-term systemic corticosteroids expose patients to unnecessary systemic
toxicity.
Q5:
A patient has been using an intranasal decongestant spray several times daily for several weeks
and now reports worsening nasal congestion. Which explanation is most likely?
A) The patient has developed bacterial pneumonia
B) Rebound congestion from prolonged topical decongestant use is likely
C) The patient has developed systemic fungal infection
D) The medication has permanently damaged the nasal septum
Rationale: Prolonged use of topical nasal decongestants can produce rebound congestion, also
called rhinitis medicamentosa. Continued frequent use can perpetuate the cycle. The other
options do not explain the classic presentation.
, 4|Page
Q6:
A patient with seasonal allergic rhinitis asks why an intranasal corticosteroid should be used
consistently rather than only when symptoms become severe. Which response is best?
A) It works only by causing immediate vasoconstriction
B) Consistent use suppresses the underlying nasal inflammatory response and provides
better control
C) It permanently cures allergic sensitivity
D) It works by killing airborne bacteria
Rationale: Intranasal corticosteroids reduce inflammatory mediators and nasal mucosal
inflammation. Their benefit is greatest with consistent use rather than sporadic rescue use. They
do not permanently eliminate the allergic predisposition or function as antibiotics.
Q7:
A patient using an intranasal corticosteroid reports recurrent minor nosebleeds. Which teaching
point is most appropriate?
A) Stop all allergy therapy permanently
B) Review administration technique, including directing the spray away from the nasal
septum
C) Double the corticosteroid dose
D) Add an oral antibiotic
Rationale: Improper spray direction can irritate the nasal septum and contribute to epistaxis.
Correct technique can reduce local adverse effects. Dose escalation or antibiotics are not
appropriate responses to uncomplicated local irritation.
Q8:
A child with allergic symptoms is being considered for an antihistamine. Which factor is
particularly important?
A) Adult dosing can always be used
B) Age, weight, formulation, and developmental considerations must guide dosing and
medication selection
C) Children are immune to antihistamine toxicity
D) First-generation antihistamines are always preferred
Rationale: Pediatric pharmacotherapy requires age- and weight-appropriate dosing and careful
attention to formulation and safety. Children are not immune to CNS or anticholinergic toxicity.
Q9:
NR566 ADVANCED PHARMACOLOGY
FOR CARE OF THE FAMILY — WEEK 8
FINAL PRACTICE QUESTIONS 1–100
AND ANSWERS UPDATED 2026/2027 |
DETAILED RATIONALES
INTRODUCTION
NR566 Advanced Pharmacology for Care of the Family requires advanced application of
pharmacologic principles across the lifespan. Publicly available 2026 course study materials
describe the Week 8 final as a multiple-choice assessment covering Weeks 5–8, with major
content areas including pharmacotherapy for the eyes, ears, nose, and skin; mental-health
pharmacotherapy; CNS disorders; and health promotion and weight-loss pharmacotherapy.
This practice bank is designed to help students prepare for challenging clinical decision-making
questions rather than simple medication memorization. The questions emphasize mechanism of
action, adverse effects, contraindications, drug interactions, monitoring, patient-specific
prescribing, lifespan considerations, and appropriate patient education. Scenarios require the
learner to integrate symptoms, comorbidities, laboratory findings, medication histories, and
safety considerations before selecting the best pharmacologic intervention. Topics include
antihistamines, corticosteroids, allergic-rhinitis therapy, psychiatric medications, antidepressants,
antipsychotics, mood stabilizers, CNS medications, Parkinson disease, Alzheimer disease,
migraine therapy, smoking cessation, immunization, obesity pharmacotherapy, and medication
safety. The goal is to provide rigorous self-assessment and identify knowledge gaps that should
be reviewed against assigned course materials and current prescribing guidance.
CONTENT AREA OVERVIEW
Content Area Questions Key Topics Weight
Antihistamines, glucocorticoids, allergic rhinitis,
Week 5 — Eyes, Ears,
1–25 cough/cold therapy, dermatologic and sensory 25%
Nose & Skin
pharmacotherapy
Depression, anxiety, bipolar disorder,
Week 6 — Mental
26–50 antipsychotics, antidepressants, mood stabilizers, 25%
Health
monitoring
Parkinson disease, Alzheimer disease, migraine,
Week 7 — CNS
51–75 seizure/CNS pharmacotherapy, neurologic adverse 25%
Disorders
effects
,2|Page
Content Area Questions Key Topics Weight
Week 8 — Health Smoking cessation, vaccines, obesity
Promotion & Weight 76–100 pharmacotherapy, contraindications, adverse 25%
Loss effects, lifestyle integration
QUESTIONS 1–100
WEEK 5 — PHARMACOTHERAPY FOR EYES, EARS,
NOSE & SKIN
Q1:
A 72-year-old patient with allergic rhinitis, benign prostatic hyperplasia, and narrow-angle
glaucoma asks for an over-the-counter antihistamine. Which prescribing consideration is most
important?
A) A first-generation antihistamine is preferred because it has stronger anticholinergic activity
B) A second-generation antihistamine is generally preferable because first-generation
agents can worsen anticholinergic and CNS effects
C) Diphenhydramine should be used at bedtime indefinitely
D) All antihistamines are contraindicated in older adults
Rationale: First-generation antihistamines have significant anticholinergic and sedating effects
that can worsen urinary retention and potentially aggravate glaucoma-related concerns. A
second-generation agent is generally preferred when an antihistamine is appropriate. Option A
is incorrect because stronger anticholinergic activity is undesirable here. Option C is
inappropriate because chronic use of a sedating first-generation agent creates unnecessary risk.
Option D is too broad; antihistamines are not universally contraindicated in older adults.
Q2:
A patient taking diphenhydramine reports that they feel awake but have difficulty performing a
complex driving task. Which counseling point is most appropriate?
A) Driving impairment occurs only when the patient reports feeling sleepy
B) First-generation antihistamines can impair reaction time and alertness even when
subjective sedation is not obvious
C) The medication improves psychomotor performance
D) Alcohol will eliminate the impairment
Rationale: First-generation antihistamines can impair psychomotor performance and reaction
time even when the patient does not perceive significant drowsiness. Alcohol and other CNS
depressants can worsen impairment. Therefore, patients should be counseled regarding driving
and hazardous activities.
,3|Page
Q3:
A 68-year-old patient with chronic allergic rhinitis has urinary hesitancy and constipation. Which
medication would create the greatest concern?
A) Fexofenadine
B) Loratadine
C) Diphenhydramine
D) Desloratadine
Rationale: Diphenhydramine is a first-generation antihistamine with substantial anticholinergic
activity, which can worsen urinary retention and constipation. The second-generation agents
listed generally have less anticholinergic and sedating activity.
Q4:
A patient with allergic rhinitis has persistent nasal congestion despite intermittent oral
antihistamine use. Which pharmacologic strategy is most appropriate when an intranasal
corticosteroid is not contraindicated?
A) Replace the antihistamine with an oral antibiotic
B) Use an intranasal corticosteroid consistently because it directly reduces nasal
inflammatory activity
C) Use an opioid cough suppressant
D) Begin systemic corticosteroids indefinitely
Rationale: Intranasal corticosteroids are highly effective for allergic rhinitis because they
reduce local inflammatory activity and symptoms such as congestion. Oral antibiotics have no
role in uncomplicated allergic rhinitis. Opioid cough suppressants do not treat nasal
inflammation. Long-term systemic corticosteroids expose patients to unnecessary systemic
toxicity.
Q5:
A patient has been using an intranasal decongestant spray several times daily for several weeks
and now reports worsening nasal congestion. Which explanation is most likely?
A) The patient has developed bacterial pneumonia
B) Rebound congestion from prolonged topical decongestant use is likely
C) The patient has developed systemic fungal infection
D) The medication has permanently damaged the nasal septum
Rationale: Prolonged use of topical nasal decongestants can produce rebound congestion, also
called rhinitis medicamentosa. Continued frequent use can perpetuate the cycle. The other
options do not explain the classic presentation.
, 4|Page
Q6:
A patient with seasonal allergic rhinitis asks why an intranasal corticosteroid should be used
consistently rather than only when symptoms become severe. Which response is best?
A) It works only by causing immediate vasoconstriction
B) Consistent use suppresses the underlying nasal inflammatory response and provides
better control
C) It permanently cures allergic sensitivity
D) It works by killing airborne bacteria
Rationale: Intranasal corticosteroids reduce inflammatory mediators and nasal mucosal
inflammation. Their benefit is greatest with consistent use rather than sporadic rescue use. They
do not permanently eliminate the allergic predisposition or function as antibiotics.
Q7:
A patient using an intranasal corticosteroid reports recurrent minor nosebleeds. Which teaching
point is most appropriate?
A) Stop all allergy therapy permanently
B) Review administration technique, including directing the spray away from the nasal
septum
C) Double the corticosteroid dose
D) Add an oral antibiotic
Rationale: Improper spray direction can irritate the nasal septum and contribute to epistaxis.
Correct technique can reduce local adverse effects. Dose escalation or antibiotics are not
appropriate responses to uncomplicated local irritation.
Q8:
A child with allergic symptoms is being considered for an antihistamine. Which factor is
particularly important?
A) Adult dosing can always be used
B) Age, weight, formulation, and developmental considerations must guide dosing and
medication selection
C) Children are immune to antihistamine toxicity
D) First-generation antihistamines are always preferred
Rationale: Pediatric pharmacotherapy requires age- and weight-appropriate dosing and careful
attention to formulation and safety. Children are not immune to CNS or anticholinergic toxicity.
Q9:
